MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20183402

September 27, 2023

Drug Information

盐酸奥洛他定滴眼液

奥乐可

眼用制剂

0.1%(5ml:5mg,以C21H23NO3计)

化学药品

September 27, 2023

Company Information

Applicant Company

江西省抚州市东乡区东红大道516号

Manufacturing Company

江西省抚州市东乡区东红大道516号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.